17
Participants
Start Date
August 31, 2008
Primary Completion Date
February 28, 2009
Study Completion Date
February 28, 2009
Ethinylestradiol/Gestodene (BAY86-5016)
transdermal patch: 0.55mg EE+2.1mg GSD; 3x7 days patch- wearing phase and a patch-free interval of 7 days (1 pre-treatment cycle, 3 treatment cycles)
Ethinylestradiol/Gestodene (BAY86-5016)
transdermal patch: 0.55mg EE+1.05 mg GSD; 3x7 days patch- wearing phase and a patch-free interval of 7 days (1 pre-treatment cycle, 3 treatment cycles
Berlin
Berlin
Berlin
Lead Sponsor
Bayer
INDUSTRY